Amino acid analogs IV:4-fluoroisoleucine

Insights

4-Fluoroisoleucine, a novel fluoroamino acid, demonstrated antifungal activity against several fungal species but showed no efficacy against Plasmodium berghei in mice. This compound was well-tolerated in animal models, indicating potential for further investigation.

Area of Science:

  • Biochemistry
  • Organic Chemistry
  • Medicinal Chemistry

Background:

  • Fluorinated amino acids are recognized for their diverse biological activities.
  • Investigating novel amino acid derivatives is crucial for discovering new therapeutic agents.

Purpose of the Study:

  • To synthesize and evaluate the biological activity of 4-Fluoroisoleucine.
  • To assess the antifungal and antimalarial potential of 4-Fluoroisoleucine.
  • To determine the toxicity profile of 4-Fluoroisoleucine in vivo.

Main Methods:

  • Synthesis of 4-Fluoroisoleucine via ammonolysis of a bromofluorinated precursor.
  • Antifungal screening against Aspergillus niger, Trichoderma viride, Myrothecium verrucaria, Trichophyton mentagrophytes, and Mucor mucedo.
  • In vivo antimalarial assay using Plasmodium berghei in mice.
  • Bacterial growth inhibition assay with Escherichia coli.

Main Results:

  • 4-Fluoroisoleucine exhibited antifungal activity against a range of fungi at concentrations between 10^3 and 10^4 µg/ml.
  • No significant inhibition of Plasmodium berghei was observed at 640 mg/kg.
  • No toxicity was noted in mice at the tested dosage.
  • 25% inhibition of Escherichia coli growth was observed at 900 µg/ml.

Conclusions:

  • 4-Fluoroisoleucine possesses notable antifungal properties.
  • The compound lacks antimalarial activity and demonstrates a favorable safety profile in mice.
  • Further research into 4-Fluoroisoleucine's antifungal mechanisms and potential applications is warranted.

Related Concept Videos

DNA Base Pairing02:27

DNA Base Pairing

Erwin Chargaff’s rules on DNA equivalence paved the way for the discovery of base pairing in DNA. Chargaff’s rules state that in a double-stranded DNA molecule,
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Amino Acid Biosynthetic Pathways01:29

Amino Acid Biosynthetic Pathways

Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which provide...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...